Target trial emulation of biologic and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis-associated interstitial lung disease. - McDermott GC; Solomon DH; Sparks JA; Desai RJ (Seminars in arthritis and rheumatism, 2026)